(1 - 8 from 12
)
KEYTRUDA® (pembrolizumab) Demonstrated Merck
www.merck.com
Dec 7, — patients,” said Dr. Martin Reck, head of the thoracic oncology department, LungenClinic Grosshansdorf, Germany. The KEYTRUDA (pembrolizumab) ... › news › keytruda-pembrolizu...
DNA Blood Test Detects Lung Cancer Mutations | ESMO
www.esmo.org
Apr 17, — ... explains Dr Martin Reck from the Department of Thoracic Oncology at Lung Clinic Grosshansdorf, Germany, who presented the findings at ... › ... › News & Press Releases
sorted by relevance / date